Publicaties - Interne-geneeskunde

01okt

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands – A nationwide study of drug usage and treatment outcomes.

»

01okt

First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival.

»

01sep

Impact of Vincristine Dose Reduction on Outcomes of Patients With Advanced-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

»

01sep

Cell-free DNA genomic and fragmentomic features for early outcome prediction in large B cell lymphoma.

»

01sep

Treatment Patterns, Outcomes and Survival Trends in T-Cell Prolymphocytic Leukemia: A Nationwide Population-Based Study in the Netherlands.

»